Incretin-based therapies for patients with type 1 diabetes: a meta-analysis

OBJECTIVE: Combined treatment with an incretin-based drug, such as a glucagon-like peptide 1 receptor agonist (GLP-1 RA) or a dipeptidyl peptidase-4 (DPP-4) inhibitor, and basal insulin is a new strategy for improving glucose control in type 1 diabetes mellitus (T1DM). We performed a meta-analysis t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lili, Shao, Zhuo, Xia, Ying, Qin, Jiabi, Xiao, Yang, Zhou, Zhiguang, Mei, Zubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410765/
https://www.ncbi.nlm.nih.gov/pubmed/30694794
http://dx.doi.org/10.1530/EC-18-0546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410765/
https://www.ncbi.nlm.nih.gov/pubmed/30694794
http://dx.doi.org/10.1530/EC-18-0546

Ejemplares similares